{
  "abstract": "The role of sexual transmission of viral, bacterial and parasitic pathogens in lower genital tract infections in women is well established. Although the sexual transmissibility of bacterial vaginosis (BV)-associated bacteria has historically been debated, recent evidence has substantially clarified this issue. A landmark randomised controlled trial by Vodstrcil et al provided compelling evidence that dual-antimicrobial treatment of male sexual partners significantly reduced BV recurrence in women, strongly supporting that sexual transmission of BV-associated pathogens occurs.1 In this issue of the Sexually Transmitted Infections journal, the very latest extensive retrospective epidemiological study from the same Melbourne Sexual Health Center group (Sutton et al) further confirms the importance of sexual transmission in BV pathogenesis, particularly in recurrent disease.2",
  "authors": [
    {
      "affiliations": [
        "Infectious Diseases, Wayne State University School of Medicine, Detroit, Michigan, USA"
      ],
      "name": "Jack D Sobel"
    },
    {
      "affiliations": [
        "Medicine/ID, University of Alabama at Birmingham, Birmingham, Alabama, USA"
      ],
      "name": "Christina A Muzny"
    }
  ],
  "title": "Sexual transmission of vaginal pathogens and male partner treatment: is it time to consider vulvovaginal candidiasis?",
  "uid": "5c518aba-94a4-59ff-9540-9a4ca7c5ccee"
}